The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acute Phase of the Infection by Covid-19

Recruiting Observational Study
Pulmonary Complications Cardiovascular Complications Renal Complications COVID-19
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
345 (estimated)
Sponsor
Hellenic Institute for the Study of Sepsis · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
More than 660 million cases of COVID-19 have been reported worldwide, with 183 million cases in the EU alone. In several people, after recovery, the effects of the first waves of COVID-19 persisted beyond the acute phase and increased the risk of chronic multiorgan symptoms and disease. Up to 70% of people affected by COVID-19 showed reduced organ function even four months or more after COVID-19 d…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Group A (comparators) 1. Adults (18 years or more) of both genders 2. Negative history of acute COVID-19 Group B (patients with ΝΟ dysfunction) 1. Adults (18 years or more) of both genders 2. History of acute COVID-19 hospitalized or non-hospitalized. All cases appearing from…
Contacts

Prof. Evangelos Giamarellos-Bourboulis

00302105831994

egiamarel@med.uoa.gr

CONTACT